ICaL and Ito mediate rate-dependent repolarization in rabbit atrial myocytes

J Physiol Biochem. 2018 Feb;74(1):57-67. doi: 10.1007/s13105-017-0603-z. Epub 2017 Dec 14.

Abstract

Rate-dependent repolarization (RDR) of action potential (AP) in cardiomyocyte plays a critical role in the genesis of arrhythmias and RDR in atrium has been linked with atrial fibrillation. However, detailed studies focusing on the role of RDR in rabbit atrium are scant. In this study, atrial cells were isolated from rabbit heart and rate-dependent property was explored in single atrial cell to elucidate the underlying mechanism. Our results indicated that rate-dependent prolongation was evident at the action potential duration at 20% (APD20) and 50% (APD50) repolarization but not at 90% repolarization (APD90) under control condition. Using transient outward potassium current (Ito) inhibitor 4-Aminopyridine (4-AP, 2 mM) effectively eliminated the changes in APD20 and APD50, and unmasked the rate-dependent reduction of APD90 which could be diminished by further adding L-type calcium current (ICaL) inhibitor nifedipine (30 μM). However, using the selective late sodium current (INaL) inhibitor GS-458967 (GS967, 1 μM) caused minimal effect on APD90 of atrial cells both in the absence and presence of 4-AP. In consistence with results from APs, Ito and ICaL displayed significant rate-dependent reduction because of their slow reactivation kinetics. In addition, the magnitude of INaL in rabbit atrium was so small that its rate-dependent changes were negligible. In conclusion, our study demonstrated that Ito and ICaL mediate RDR of AP in rabbit atrium, while minimal effect of INaL was seen.

Keywords: Atrial myocytes; L-type calcium current; Late sodium current; Rate-dependent repolarization; Transient outward potassium current.

MeSH terms

  • 4-Aminopyridine / pharmacology
  • Action Potentials / drug effects
  • Animals
  • Anti-Arrhythmia Agents / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / chemistry
  • Calcium Channels, L-Type / metabolism*
  • Cells, Cultured
  • Electrophysiological Phenomena / drug effects
  • Heart Atria / cytology
  • Heart Atria / drug effects
  • Heart Atria / metabolism*
  • Kinetics
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Nifedipine / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Pyridines / pharmacology
  • Rabbits
  • Single-Cell Analysis
  • Sodium Channel Blockers / pharmacology
  • Sodium Channels / chemistry
  • Sodium Channels / metabolism*
  • Triazoles / pharmacology

Substances

  • 6-(4-(trifluoromethoxy)phenyl)-3-(trifluoromethyl)(1,2,4)triazolo(4,3-a)pyridine
  • Anti-Arrhythmia Agents
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Potassium Channel Blockers
  • Pyridines
  • Sodium Channel Blockers
  • Sodium Channels
  • Triazoles
  • 4-Aminopyridine
  • Nifedipine